Michael Avruch
Fortuna: 17 M $ al 31/05/2026
Fortuna: 17 M $ al 31/05/2026
Mr. Michael Avruch is an Independent Director at Alpha Tau Medical Ltd., a Chief Executive & Financial Officer at Sabor Group Usa and a CEO, CFO & Director at Abor Group.
He is on the Board of Directors at Alpha Tau Medical Ltd. and Abor Group.
He received his undergraduate degree from The Jerusalem College of Technology and an MBA from Bar-Ilan University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALPHA TAU MEDICAL LTD 1,79 % | 18/03/2026 | 1.571.961 ( 1,79 % ) | 17 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALPHA TAU MEDICAL LTD. | Director/Miembro de la Junta | 01/01/2016 |
Abor Group | Director Ejecutivo | 01/01/1998 |
Sabor Group Usa | Director Ejecutivo | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 5 |
|---|---|
The Jerusalem College of Technology
The Jerusalem College of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. Medical SpecialtiesHealth Technology Specializes in research, development and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer | Health Technology |
Abor Group | |
Sabor Group Usa |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.